12 Dec, 10:19 - Indian

SENSEX 81511.93 (-0.02)

Nifty 50 24625.7 (-0.07)

Nifty Bank 53396.9 (0.01)

Nifty IT 45964.25 (1.35)

Nifty Midcap 100 59300.2 (0.01)

Nifty Next 50 73239.75 (-0.07)

Nifty Pharma 22285.75 (-0.08)

Nifty Smallcap 100 19637.15 (-0.10)

12 Dec, 10:19 - Global

NIKKEI 225 39901.1 (1.34)

HANG SENG 20429.28 (1.36)

S&P 6096.75 (-0.13)

Login/Signup

You are Here : Home > Research

31-Jan-2024

Dr Reddys Laboratories

NP up 11.01%

'For the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Dr Reddys Laboratories has increased 6.58% to Rs 7236.8 crore compared to quarter ended Dec 2022.  Sales of Pharmaceutical Services segment has gone up 2.68% to Rs 1,058.00 crore (accounting for 14.12% of total sales).  Sales of Global Generics segment has gone up 6.49% to Rs 6,312.40 crore (accounting for 84.26% of total sales).  Sales of Others segment has gone up 73.08% to Rs 121.50 crore (accounting for 1.62% of total sales).  Inter-segment sales rose Rs 238.40 crore to Rs 255.10 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 5.26% to Rs 4,220.70 crore.  PBIT of Pharmaceutical Services segment rose 63.27% to Rs 230.70 crore (accounting for 5.47% of total PBIT).  PBIT of Global Generics segment rose 2.15% to Rs 3,907.70 crore (accounting for 92.58% of total PBIT). &...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information